Erschienen in:
27.11.2018 | Endocrine Tumors
Management of Regional Lymph Nodes in Patients with Merkel Cell Carcinoma Following a Positive Sentinel Node Biopsy: Less May be More, But is Either Enough?
verfasst von:
George Hruby, MBChB, Alexander Guminski, MBBS, PhD, John F. Thompson, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 2/2019
Einloggen, um Zugang zu erhalten
Excerpt
Merkel cell carcinoma (MCC) is an aggressive cutaneous tumor that is generally regarded as rare, but population-based data indicate a rapidly increasing incidence in many parts of the world, including the US, Australia, New Zealand, and Europe.
1–6 Current clinical practice guidelines recommend sentinel lymph node (SLN) biopsy for clinically node-negative MCC patients, and completion lymph node dissection (CLND) and/or radiation therapy (RT) for those found to be SLN-positive. …